Zhude Tu Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

7/2022	Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1.
11/2021	In vitro characterization of [3H]VAT in cells, animal and human brain tissues for vesicular acetylcholine transporter.
2/2021	Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer's Disease and Parkinson's Disease Treatment (2011-2020).
2/2016	Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhude Tu Research Topics

Disease

10	Neoplasms (Cancer) 11/2020 - 02/2006
7	Inflammation (Inflammations) 07/2023 - 08/2015
7	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 02/2016
6	Parkinson Disease (Parkinson's Disease) 02/2021 - 08/2012
6	Breast Neoplasms (Breast Cancer) 03/2014 - 07/2005
5	Neuroinflammatory Diseases 04/2024 - 05/2017
4	Multiple Sclerosis 04/2024 - 10/2016
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 02/2016
3	Cognitive Dysfunction 01/2022 - 11/2018
3	Dementia (Dementias) 01/2018 - 04/2015
2	Atherosclerosis 02/2024 - 01/2018
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 03/2011
2	Schizophrenia (Dementia Praecox) 01/2022 - 01/2016
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 05/2017
2	Melanoma (Melanoma, Malignant) 03/2014 - 02/2006
2	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 02/2006
1	Metabolic Diseases (Metabolic Disease) 07/2023
1	Treatment-Resistant Depressive Disorder 04/2022
1	Amyloidosis 01/2022
1	Thrombosis (Thrombus) 02/2021
1	Stroke (Strokes) 02/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Tauopathies 02/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Hyperplasia 01/2017
1	Vascular System Injuries 01/2017
1	Neointima 01/2017
1	Dystonia (Limb Dystonia) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 08/2015
1	Disease Progression 01/2013
1	Carcinoma (Carcinomatosis) 01/2013
1	Opioid-Related Disorders (Opiate Addiction) 04/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2006
1	Necrosis 07/2005

Drug/Important Bio-Agent (IBA)

11	Sphingosine-1-Phosphate ReceptorsIBA 04/2024 - 08/2015
9	LigandsIBA 02/2024 - 07/2005
8	Biomarkers (Surrogate Marker)IBA 07/2023 - 03/2014
7	Cholinergic Agents (Cholinergics)IBA 11/2021 - 04/2015
6	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 11/2021 - 04/2015
6	sigma-2 receptorIBA 03/2014 - 02/2006
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2023 - 11/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2018
3	SynucleinsIBA 01/2018 - 08/2012
3	benzamideIBA 01/2013 - 06/2006
2	Buprenorphine (Subutex)FDA LinkGeneric 04/2022 - 04/2011
2	LipopolysaccharidesIBA 04/2018 - 05/2017
2	Purinergic P2X7 ReceptorsIBA 02/2018 - 05/2017
2	Carbon-11IBA 01/2018 - 07/2005
2	Fluorine-18IBA 01/2018 - 12/2010
2	Monoclonal AntibodiesIBA 10/2013 - 11/2012
1	ChemokinesIBA 02/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AnticoagulantsIBA 02/2021
1	pyrazoleIBA 02/2021
1	apixabanIBA 02/2021
1	Adenosine Diphosphate (ADP)IBA 11/2020
1	sphingosine kinaseIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	alpha-SynucleinIBA 11/2018
1	SEW2871IBA 04/2018
1	TZ6019IBA 02/2018
1	ElementsIBA 05/2017
1	salicylhydroxamic acid (SHAM)IBA 05/2017
1	N- (2- chloro- 3- (trifluoromethyl)benzyl)- N- methyl- 5- oxopyrrolidine- 2- carboxamideIBA 05/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2016
1	CaspasesIBA 03/2014
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2013
1	vorozoleIBA 01/2013
1	Bexarotene (LGD1069)FDA Link 01/2013
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2013
1	Bromodeoxyuridine (BrdU)IBA 01/2013
1	CarbohydratesIBA 11/2012
1	Polysaccharides (Glycans)IBA 11/2012
1	AntigensIBA 11/2012
1	AntibodiesIBA 11/2012
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2011
1	Iodine-125IBA 12/2010
1	SV119IBA 11/2010
1	Gemcitabine FDA Link 11/2010
1	FluorineIBA 07/2007
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 07/2005

Therapy/Procedure

5	Therapeutics 07/2022 - 07/2011
1	Intravenous Injections 01/2021